Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Otto

Showing results (441-450 of 558) with videos related to

Pageof 56
Sort By:
Antiviral Chemistry & Chemotherapy|June 7, 2003
HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset)Romas Geleziunas, Karen Gallagher, Hangchun Zhang, et al.
Journal of Medical Imaging and Radiation Oncology|November 25, 2015
Outcomes of mucosal melanoma of the head and neckJessica M Frakes, Tobin J Strom, Arash O Naghavi, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 13, 2006
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agentsByoung-Kwon Chun, Peiyuan Wang, Abdalla Hassan, et al.
Journal of Neuroscience Methods|April 27, 2010
Evaluation of tissue components in the peripheral nervous system using Sirius red staining and immunohistochemistry: a comparative study (human, pig, rat)D Kaemmer, A Bozkurt, J Otto, et al.
Oral Oncology|May 5, 2015
Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancerTobin J Strom, Andy M Trotti, Julie Kish, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 12, 2018
A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcersCharles E Ananian, Yadwinder S Dhillon, Carl C Van Gils, et al.
Journal of Geriatric Oncology|October 11, 2016
Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70yearsTobin J Strom, Arash O Naghavi, Andy M Trotti, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.
Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteaseM J Otto, S Garber, D L Winslow, et al.
Pageof 56

Showing results (441-450 of 558) with videos related to

Sort By:
Pageof 56
Antiviral Chemistry & Chemotherapy|June 7, 2003
HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset)Romas Geleziunas, Karen Gallagher, Hangchun Zhang, et al.
Journal of Medical Imaging and Radiation Oncology|November 25, 2015
Outcomes of mucosal melanoma of the head and neckJessica M Frakes, Tobin J Strom, Arash O Naghavi, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 13, 2006
Synthesis and biological activity of 5',9-anhydro-3-purine-isonucleosides as potential anti-hepatitis C virus agentsByoung-Kwon Chun, Peiyuan Wang, Abdalla Hassan, et al.
Journal of Neuroscience Methods|April 27, 2010
Evaluation of tissue components in the peripheral nervous system using Sirius red staining and immunohistochemistry: a comparative study (human, pig, rat)D Kaemmer, A Bozkurt, J Otto, et al.
Oral Oncology|May 5, 2015
Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancerTobin J Strom, Andy M Trotti, Julie Kish, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 12, 2018
A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcersCharles E Ananian, Yadwinder S Dhillon, Carl C Van Gils, et al.
Journal of Geriatric Oncology|October 11, 2016
Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70yearsTobin J Strom, Arash O Naghavi, Andy M Trotti, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2007
The mechanism of action of beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine involves a second metabolic pathway leading to beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymeraseEisuke Murakami, Congrong Niu, Haiying Bao, et al.
Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 proteaseM J Otto, S Garber, D L Winslow, et al.
Pageof 56